SERA PROGNOSTICS, INC. Depreciation
SERA PROGNOSTICS, INC. (SERA) reported Depreciation of $200.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-12
- SERA PROGNOSTICS, INC. depreciation for the quarter ending 2026-06-30 was $200.00K, a 0.00% change year-over-year.
- SERA PROGNOSTICS, INC. depreciation for the quarter ending 2026-03-31 was $200.00K, a 0.00% change year-over-year.
- SERA PROGNOSTICS, INC. depreciation for the quarter ending 2025-12-31 was $200.00K, a 0.00% change year-over-year.
- SERA PROGNOSTICS, INC. depreciation for the quarter ending 2025-09-30 was $200.00K, a 0.00% change year-over-year.
- SERA PROGNOSTICS, INC. depreciation for fiscal 2025 was $800.00K, a 0.00% change from fiscal 2024.
- SERA PROGNOSTICS, INC. depreciation for fiscal 2024 was $800.00K.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2026-06-30 | $200.00K 10-Q · filed 2026-08-12 | $300.00K 10-Q · filed 2026-08-12 | $600.00K derived: sum of 3 quarters · filed 2026-08-12 | $800.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $200.00K 10-Q · filed 2026-05-06 | $400.00K derived: sum of 2 quarters · filed 2026-05-06 | $600.00K derived: sum of 3 quarters · filed 2026-05-06 | $800.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $400.00K derived: sum of 2 quarters · filed 2026-03-18 | $600.00K derived: sum of 3 quarters · filed 2026-08-12 | $800.00K 10-K · filed 2026-03-18 |
| 2025-09-30 | $200.00K 10-Q · filed 2025-11-13 | $400.00K derived: sum of 2 quarters · filed 2026-08-12 | $600.00K 10-Q · filed 2025-11-13 | $800.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $200.00K 10-Q · filed 2026-08-12 | $400.00K 10-Q · filed 2026-08-12 | $600.00K derived: sum of 3 quarters · filed 2026-08-12 | $800.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $200.00K 10-Q · filed 2026-05-06 | $400.00K derived: sum of 2 quarters · filed 2026-05-06 | $600.00K derived: sum of 3 quarters · filed 2026-05-06 | $800.00K derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $400.00K derived: sum of 2 quarters · filed 2026-03-18 | $600.00K derived: sum of 3 quarters · filed 2026-03-18 | $800.00K 10-K · filed 2026-03-18 |
| 2024-09-30 | $200.00K 10-Q · filed 2025-11-13 | $400.00K derived: sum of 2 quarters · filed 2025-11-13 | $600.00K 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $200.00K 10-Q · filed 2025-08-06 | $400.00K 10-Q · filed 2025-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |